The antibiotic minocycline can reduce brain damage and physical disability in stroke patients who receive the drug within 24 hours after the event, Israeli scientists revealed. Current standard stroke therapies need to be administered three hours after the event in order to be effective, and the experts hope that minocycline's anti-inflammatory properties could soon lead to better stroke treatments.

Related Summaries